RxDoctor Payments Data

Erik Dunki Jacobs, MD

Surgical Oncology · Cincinnati, OHNPI 1639461882

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,720 of the $2,743 with a category attached, or 62.7%. 10 manufacturers reported payments, led by Histosonics, Inc. at 43.1% of the total. 2025 is the largest year on record at $1,418, more than ten times the $101 reported in 2019.

$2,743in general payments, 2019–2025

Across 17 payments — averaging $161.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$1K
  • Medtronic$805
  • Legacy Ortho LLC$327
  • Sirtex Medical Inc$172
  • Intuitive Surgical$101
  • Teleflex LLC$90
  • plus $66 from 4 others
$2,804in research payments, 2019–2025

Across 6 payments — averaging $467.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$3K

What the payments were for

  • Travel & lodging$1,72063%
  • Food & beverage$1,02337%

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,743 in reported general payments places this provider in the 70th percentile of 69 surgical oncology providers in Ohio.

See all surgical oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$121,372
Medicare patients
153
Services billed
423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium11$64

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →